RECRUITING
I'm interested ...!!
The Impact of Low Pressure Pneumo in RARP II
The purpose of this study is to evaluate clinical significance of low pressure pneumoperitoneum during robotically assisted radical prostatectomy (RARP).
Conditions:
🦠 Prostate Cancer
🗓️ Study Start (Actual) 4 August 2020
🗓️ Primary Completion (Estimated) 30 June 2024
✅ Study Completion (Estimated) 30 June 2025
👥 Enrollment (Estimated) 600
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Wyoming, Michigan, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • - Male 40 years of age or older
    • * Diagnosis of prostate cancer
    • * Have been evaluated to be fit for proposed surgery
    • * Patients able to consent

    Exclusion Criteria:

    • - Patients unable to consent (cognitively impaired)
    • • Non-English speaking
Ages Eligible for Study: 40 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: MALE
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 14 May 2020
  • First Submitted that Met QC Criteria 14 May 2020
  • First Posted 19 May 2020

Study Record Updates

  • Last Update Submitted that Met QC Criteria 11 October 2023
  • Last Update Posted 12 October 2023
  • Last Verified March 2023
I'm interested ...!!